Do you currently have a solid tumor that has advanced or progressed after treatment with a PARP inhibitor? Does your tumor have genetic abnormalities in the system that repairs damage to DNA? If so, you may be able to take part in a research study to see if a new drug will be able to slow the growth of your cancer. Travel reimbursement and compensation provided if eligible for participation.

Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.

The purpose of this study is to look at the effectiveness of a combination of treatments, polatuzumab vedotin with rituximab, gemcitabine, dexamethasone, and cisplatin (PV-RGDP) at treating relapsed or refractory diffuse large B-cell lymphoma.

The purpose of this study is to better understand how young adults (ages 18 - 39) who have had cancer use entertainment media during and after cancer treatment.

This is a research study to find out which type of sedentary behavior, or sitting, is most strongly associated with cardiovascular disease (CVD) risk in endometrial cancer survivors. Additionally, we hope to better understand your perception of sedentary behavior and sedentary behavior reduction. The findings from this research study will be used to design a future sedentary behavior reduction intervention for endometrial cancer survivors. Participation in this study includes one assessment visit (during your regularly scheduled clinic visits) where we will measure your blood pressure and arterial stiffness using a blood-pressure like non-invasive device. Additionally, during this visit, you will answer questionnaires, complete a short physical function test (i.e., balance, walking, standing), and be instructed in how to use an accelerometer (movement tracking device worn on your upper thigh) paired with a smart-phone application that will ask you questions about your physical activities and sedentary behavior for 7-days following your

Do you have glioblastoma? Has your cancer either come back or did not improve after the treatments you received? If so, you may be eligible to participate in this gene therapy research study that wants to learn if a new way to modify your immune cells for use as possible treatment is safe and at what dose.

Do you have a type of cancer known as Nonseminmatous Germ Cell Tumor (NSGCT)? Has your cancer come back, or not get better with the last treatment you received? If so, you may be able to participate in a gene therapy study to see if we can use your body's own immune cells as a treatment for your NSGCT.

In this study, we will collect blood samples to help us learn if a blood test can be used to identify lung cancers. We also want to learn if a blood test can help us identify other types of cancers and health conditions.

In this study, we want to use an online survey for people newly diagnosed with metastatic breast cancer to ask questions about physical and emotional health. We hope to use the results of this survey to design a program to help future patients tolerate treatment better.

Have you been diagnosed with Leukemia and are looking for another treatment option? In this study we are looking to see if the study drug DSP-5336 can help control Leukemia or achieve remission.